Cited by 368Genetic Neurodegenerative DiseasesMitochondrial Function and PathologyParkinson's Disease Mechanisms and Treatments

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid

Brouillet, Emmanuel, Jenkins, Bruce G., Hyman, Bradley T., Ferrante, Robert J., Kowall, Neil W., Srivastava, Rachana, Roy, Deborah Samanta, Rosen, Bruce R., Beal, M. Flint·1993·Journal of Neurochemistry

DOI 10.1111/j.1471-4159.1993.tb05859.x

Open this paper in CoChat — free account

Abstract

The mechanisms of delayed onset and cell death in Huntington's disease (HD) are unknown. One possibility is that a genetic defect in energy metabolism may result in slow excitotoxic neuronal death. Therefore, we examined the effects of age on striatal lesions produced by local administration of the mitochondrial toxin 3-nitropropionic acid in rats. In vivo chemical shift magnetic resonance imaging showed marked increases in striatal lactate concentrations that significantly correlated with increasing age. Histologic and neurochemical studies showed a striking age dependence of the lesions, with 4- and 12-month-old animals being much more susceptible than 1-month-old animals. Continuous systemic administration of low doses of 3-nitropropionic acid for 1 month resulted in striatal lesions showing growth-related changes in dendrites of striatal spiny neurons using the Golgi technique. These results show that a known mitochondrial toxin can produce selective axon-sparing striatal lesions showing both the age dependence and striatal spiny neuron dendritic changes that characterize HD.

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.1993.tb05859.x

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
Beal, M. F. (1992) · Annals of Neurology · doi:10.1002/ana.410310202 · Cited by 962
Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced
Novelli, A., Reilly, J. A., Lysko, P. G., & Henneberry, R. C. (1988) · Brain Research · doi:10.1016/0006-8993(88)90765-2 · Cited by 961
Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing
Trounce, I., Byrne, E., & Marzuki, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92143-0 · Cited by 730
Evidence for Degenerative and Regenerative Changes in Neostriatal Spiny Neurons in Huntington's Disease
Graveland, G. A., Williams, R. S., & DiFiglia, M. (1985) · Science · doi:10.1126/science.3155875 · Cited by 612
3-Nitropropionic Acid - Exogenous Animal Neurotoxin and Possible Human Striatal Toxin
Ludolph, A. C., He, F., Spencer, P. S., Hammerstad, J. P., & Sabri, M. I. (1991) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100032212 · Cited by 484
3-Nitropropionate, the toxic substance of Indigofera , is a suicide inactivator of succinate dehydrogenase
Alston, T. A., Mela, L., & Bright, H. J. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.9.3767 · Cited by 382
Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry
Ferrante, R., Kowall, N., & Richardson, E. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-12-03877.1991 · Cited by 306
Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: A type of hypoxic (energy deficient) brain damage
Hamilton, B. F., & Gould, D. H. (1987) · Acta Neuropathologica · doi:10.1007/bf00691103 · Cited by 230
1‐Methyl‐4‐Phenylpyridinium Produces Excitotoxic Lesions in Rat Striatum as a Result of Impairment of Oxidative Metabolism
Storey, E., Hyman, B. T., Jenkins, B. G., Brouillet, E., Miller, J. M., Rosen, B. R., & Beal, M. F. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10080.x · Cited by 164
Chemically induced hypoglycemia and anoxia: relationship to glutamate receptor-mediated toxicity in retina.
Zeevalk, G. D., & Nicklas, W. J. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13234-5 · Cited by 164

Show all 16 references

Research works printed but not linked: 5

Beal M. F., 1992, Local and systemic administration of 3‐nitropropionic acid results in excitotoxic striatal lesions, Soc. Neurosci. Abstr., 18, 84
Koroshetz W. J., 1992, Localized proton‐NMR spectroscopy in patients with Huntington's disease (HD) demonstrates abnormal lactate levels in occipital cortex: evidence for compromised metabolism in HD, Neurology, 42, 319
Langston J. W., 1989, Aging, Vol. 36: Parkinsonism and Aging, 145
Linnane A. W., 1990, Mitochondrial gene mutation: the aging process and degenerative diseases, Biochem. Int., 22, 1067
Ludolph A. C., 1992, 3‐Nitropropionic acid decreases cellular energy levels and causes neuronal degeneration in cortical explants, Neurodegeneration, 1, 21

Sorted by citations

Items 301–368 of 368

Infant mice with glutaric acidaemia type I have increased vulnerability to 3‐nitropropionic acid toxicity
Bjugstad, K. B., Crnic, L. S., Goodman, S. I., & Freed, C. R. (2006) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-006-0102-9 · Cited by 3
Age-Dependent Vulnerability of the Striatal Mitochondrial to 3-Nitropropionic Acid
Nasr, P., & Delorme, T. (2007) · The Knowledge Bank (The Ohio State University) · Cited by 3
THE EFFECT OF NORMOBARIC HYPEROXIA ON SUPEROXIDE DISMUTASE ACTIVITY AND NEUROLOGICAL DEFICITS IN AN ANIMAL MODEL OF HUNTINGTON DISEASE
Bigdeli, M. R., & Rahnama, M. (2009) · Cited by 3
Mechanisms of Neuronal Death in Huntington's Disease
Koliatsos, V. E., Portera‐Cailliau, C., Schilling, G., Borchelt, D. B., Bêcher, M. W., & Ross, C. A. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-106-0_5 · Cited by 4
Chapter 5 Mitochondrial Abnormalities in Neurodegenerative Disorders
Tabrizi, S. J., & Schapira, A. H. V. (2002) · Blue books of practical neurology · doi:10.1016/s1877-3419(09)70064-9 · Cited by 3
Calcium homeostasis in the central nervous system: adaptation to neurodegeneration
Adroer, R., Ramonet, D., Mahy, N., de Yerba, L., & Rodríguez, M. J. (2001) · Contributions to science · Cited by 2
Mitochondrial Approaches to Neuroprotection
Beal, M. F. (2002) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-06274-6_4 · Cited by 2
Animal Models of Neurological Disorders
Kallman, M. J. (2016) · Springer eBooks · doi:10.1007/978-3-642-27728-3_33-2 · Cited by 2
Animal Models for Huntington's Disease
Ortega, Z., & Lucas, J. J. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/bk9781849731843-00214 · Cited by 2
Huntington disease
Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00014-7 · Cited by 2
Apoptosis in Huntington disease and animal models
Koliatsos, V. E., Portera‐Cailliau, C., Schilling, G., Borchelt, D. B., Bêcher, M. W., & Ross, C. A. (2001) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(01)06008-4 · Cited by 2
Estrogen blocks 3-nitropropionic acid-induced[Ca[2+]]i increase and cell damage in cultured rat cerebral endothelial cells
Mogami, M. (2003) · Cited by 2
Clinical Manifestations and Mechanisms of Action of Environmental Mitochondrial Toxins
Sabri, M. I., Spencer, P. S., Baggia, S., & Ludolph, A. C. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-692-8_1 · Cited by 2
Systemic Administration of 3-Nitropropionic Acid
Brouillet, E., Hantraye, P., & Beal, M. F. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-691-1_16 · Cited by 2
Sodium Azide-Induced Neurotoxicity
Wang, Y., & Borlongan, C. V. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-692-8_16 · Cited by 2
Huntington’s Disease and DRPLA: Two Glutamine Repeat Diseases
Ross, C. A., Bêcher, M. W., & Koliatsos, V. E. (1999) · Humana Press eBooks · doi:10.1007/978-1-4612-1602-5_23 · Cited by 2
Mitochondrial Inhibition and Neuronal Death in Huntington’s Disease
Behrens, M. I. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-692-8_12 · Cited by 2
The 3-Nitropropionic Acid Model of Huntington’s Disease
Page, K. J., Meldrum, A., & Dunnett, S. B. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-692-8_10 · Cited by 1
Microglia, Calcification and Neurodegenerative Diseases
Jose, M., Mahy, N., & Manuel, J. (2011) · InTech eBooks · doi:10.5772/28464 · Cited by 1
Excitotoxicity in Huntington’s Disease
Beal, M. F. (2004) · Springer eBooks · doi:10.1007/978-1-4419-8959-8_13 · Cited by 1
REVIEW ARTICLE Mechanisms of neurodegeneration in Huntington's disease
Gil‐Mohapel, J., & Rego, A. C. (2008) · Cited by 1
Replicating Huntington Disease’s Phenotype in Nonhuman Primates
Hantraye, P., Palfi, S., Mittoux, V., Dautry, C., Condé, F., & Brouillet, E. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-691-1_17 · Cited by 1
Mitochondrial Dynamics and Huntington’s Disease: A Dance of Fate
Wang, H., Karbowski, M., & Monteiro, M. J. (2011) · Springer eBooks · doi:10.1007/978-94-007-1291-1_9 · Cited by 1
Huntington disease
Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00013-5 · Cited by 1
Survey of the Spectrum of Classic Selective Neurotoxins
Kostrzewa, R. M. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_246 · Cited by 1
Endogenous Kynurenic Acid and Neurotoxicity
Urbańska, E. M., Chmiel-Perzyńska, I., Perzyński, A., Derkacz, M., & Owe‐Larsson, B. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_92 · Cited by 1
Glutamate Receptors and Excitotoxic Mechanisms in Alzheimer’s Disease
Geddes, J. W. (1999) · Cerebral cortex · doi:10.1007/978-1-4615-4885-0_18 · Cited by 1
Comparative Study on 3-Nitropropionic Acid Neurotoxicity
Borlongan, C. V., Shimizu, T., & Sanberg, P. R. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-692-8_6 · Cited by 1
Energy Failure, Glutamate and Neuropathology: Relevance to Neurodegenerative Disorders
Turski, L., & Ikonomidou, C. (1994) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4684-9203-3_12 · Cited by 1
HUNTINGTON’S DISEASE: A HARD NUT TO BREAK
Thakur, T., Mehan, S., Kaur, R., & Kalra, S. (2015) · doi:10.13140/rg.2.2.21568.84480 · Cited by 1
Animal Models of Neurological Disorders
Kallman, M. J. (2015) · Springer eBooks · doi:10.1007/978-3-319-05392-9_33 · Cited by 1
Ginsenosides attenuate the 3-nitropropioic acid-induced rat striatal degeneration in an age-dependent manner
Kim, J. (2005) · Journal of Ginseng Research · doi:10.5142/jgr.2005.29.2.100
THE EFFECT OF NORMOBARIC HYPEROXIA ON SUPEROXIDE DISMUTASE ACTIVITY AND NEUROLOGICAL DEFICITS IN AN ANIMAL MODEL OF HUNTINGTON DISEASE
Bigdeli, M. R., & Rahnama, M. (2009) · Cited by 3
Disorders of the mitochondrial respiratory chain
Schapira, A. H. V. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.063
Transfert de genes a potentiel therapeutique dans des modeles de la maladie de huntington developpes chez le rat
Bemelmans, A. (1999)
Interacciones de drogas anti-hipertensivas
Acuña, F. P. (2008) · Revista Latinoamericana de Hipertensión/Revista Latinoamericana de Hipertensiòn
Neuroprotective Strategies Against Cellular Hypoxia
Riepe, M. W. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-692-8_17
Mitochondrial Dysfunction, Aging, and Huntington’s Disease
Beal, M. F. (1994) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4684-9203-3_11
Molecular Pathways of Mitochondrial Dysfunction in Neurodegeneration: the Paradigms of Parkinson's and Huntington's Diseases
Rego, A. C., Cardoso, S. M., & Oliveira, C. R. (2007) · Springer eBooks · doi:10.1007/978-0-387-70830-0_9 · Cited by 1
Neural Transplantation and Huntington’s Disease
Borlongan, C. V., Stahl, C. E., Freeman, T. B., Hauser, R. A., & Sanberg, P. R. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-692-8_19
Bioenergetic Defects and Oxidative Damage in Transgenic Mouse Models of Neurodegenerative Disorders
Browne, S. E. (2003) · Defense Technical Information Center (DTIC) · doi:10.21236/ada419306
Chapter 12 EXCITOTOXICITY IN HUNTINGTON'S DISEASE
Beal, M. F. (2004)
Expression of Calponin 3 in the Striatum Following 3-Nitropropionic Acid-induced Neurotoxicity
Choi, Y. (2013) · Journal of Life Science · doi:10.5352/jls.2013.23.1.125
3-Nitropropionic Acid and Other Metabolic Toxin Lesions of the Striatum
Borlongan, C. V., & Sanberg, P. R. (2011) · Neuromethods · doi:10.1007/978-1-61779-301-1_5
Site-selective action
Slikker, W., & Jr (2010) · Taylor & Francis eBooks · doi:10.4324/9780203219096_chapter_2
Role of Mitochondria in Parkinson’s Disease and Huntington’s Disease
Schapira, A. H. V. (2012) · Oxidative stress and disease · doi:10.1201/b12308-23
_-Nitropropionic Acid in the Diet
Griffiths, J., Burdock, G. A., Carabin, I. G., & Soni, M. G. (2004) · Reviews in food and nutrition toxicity · doi:10.1201/9781420038323.ch5
Impairment of Neurotransmitter Metabolism and Function by Neurotoxicants
Aschner, M., & Sonnewald, U. (2004) · Humana Press eBooks · doi:10.1385/1-59259-651-7:133
Stem cell therapies for Huntington's disease
Crane, A. T., Rossignol, J., & Dunbar, G. L. (2016) · Wiley eBooks · doi:10.1002/9781118907474.ch40
Effects of Inhibitors of the Mitochondrial Electron Transport Chain on Fatty Acid Beta-Oxidation in Rat Brain Cultured Astrocytes
Esfandiari, A., & Paturneau-Jouas, M. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5405-9_124
Fabaceae Lindl.
Burrows, G. E., & Tyrl, R. J. (2012) · doi:10.1002/9781118413425.ch35
Huntington's Disease
Browne, S. E., & Beal, M. F. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50051-2
Gene-environment interactions between mutant huntingtin and manganese exposure alter striatal neurochemistry and medium spiny neuron morphology.
Madison, J. L. (2011)
Literatur
Hellweg, R. (2000) · Monographien aus dem Gesamtgebiete der Psychiatrie · doi:10.1007/978-3-642-96006-2_17
Animal Models of Neurological Disorders
Kallman, M. J. (2015) · Springer eBooks · doi:10.1007/978-3-642-27728-3_33-1
Faculty Opinions recommendation of Neurochemical changes in Huntington R6/2 mouse striatum detected by in vivo 1H NMR spectroscopy.
Donato, S. D. (2007) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1063718.519739
Site-selective action
Slikker, W. (2002) · CRC Press eBooks · doi:10.1201/9780203219096.ch2
Malonate
Meldrum, A., Page, K. J., Everitt, B. J., & Dunnett, S. B. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-692-8_14
Survey of the Spectrum of Classic Selective Neurotoxins
Kostrzewa, R. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-71519-9_246-1
Étude de l'implication potentielle des marqueurs du striatum dans la maladie de Huntington
Galvan, L. (2011) · theses.fr (ABES) · doi:10.70675/ebf9c275z3ce2z474dz8d5az68c2c35df509
Trafficking Regulation and Energetics
Rivas, M. V. H. (2014) · theses.fr (ABES) · doi:10.70675/5ffde918zb7aaz4749z8ad1ze7a28ef65de9
Développement de l’imagerie métabolique par IRM-CEST : application à la maladie de Huntington
Pépin, J. (2018) · theses.fr (ABES) · doi:10.70675/36f26e42z6133z47dbz84a3z07fae7850aa0
Reconstitution du réseau corticostriatal et cible thérapeutique dans la maladie de Huntington
Virlogeux, A. (2018) · theses.fr (ABES) · doi:10.70675/92b9e042zfafcz42e8z890bz6c7ca43e2613
Role of the cholesterol hydroxylase enzyme CYP46A1 in cholesterol metabolism and neuroprotection in Huntington's disease
Kacher, R. (2019) · theses.fr (ABES) · doi:10.70675/2e6ac10bz0700z4936z81f8z18565a62aaf5
Rôle des altérations transcriptionnelles et épigénétiques dans les déficits comportementaux de la maladie de Huntington
Lotz, C. (2019) · theses.fr (ABES) · doi:10.70675/35213e27zda27z484az886azd1ed4013e75a
The role of the serum response factor in the pathogenesis of Huntington's disease
Awada, A. (2021) · theses.fr (ABES) · doi:10.70675/fabef4b5z9d78z440bz99f2z9be7d0814a03
Acidic cannabinoids in brain disorders: Neurobiological mechanisms, preclinical evidence, and translational challenges
Rava, A., Trapano, M. D., Tse, C., Ji, L., Bid, H. K., & Trezza, V. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.107005
Induction and Reversal of Cognitive Deficits in a Primate Model of Huntington's Disease
Palfi, S., Brouillet, E., Condé, F., & Hantraye, P. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-326-2_12

Authors: Brouillet, E., Jenkins, B. G., Hyman, B. T., Ferrante, R. J., Kowall, N. W., Srivastava, R., Roy, D. S., Rosen, B. R., & Beal, M. F.
Affiliations: Massachusetts General Hospital (US)
Harvard University (US)
Corresponding author: Beal, M. Flint
ORCID: Brouillet, Emmanuel
Hyman, Bradley T.
Kowall, Neil W.
Rosen, Bruce R.
Venue: Journal of Neurochemistry
Publisher: Wiley
Published: 1993-01
Volume: 60
Issue: 1
Pages: 356-359
ISSN: 0022-3042 (ISSN-L)
1471-4159
DOI: 10.1111/j.1471-4159.1993.tb05859.x
OpenAlex: W1983729920
Cited by: 367
References: 16
Citations by year: 2026: 1 · 2024: 2 · 2023: 1 · 2022: 6 · 2021: 5 · 2020: 4 · 2019: 4 · 2018: 7 · 2017: 6 · 2016: 11 · 2015: 3 · 2014: 11 · 2013: 6 · 2012: 10
FWCI: 6.62
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 5025 d)
Locations: Journal of Neurochemistry (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Public Health Service (16367)
National Institute of Neurological Disorders and Stroke (NS10828)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords: Huntington's disease, 3-nitropropionic acid, striatum, age-related susceptibility, mitochondrial toxins, dendritic changes, lactate, energy metabolism, excitotoxicity, neurodegeneration
MeSH terms: Adenosine Triphosphate, Aging, Corpus Striatum, Lactates, Mitochondria, Neurotoxins, Nitro Compounds, Propionates, Lactic Acid, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks